Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 66, Issue 12, Pages 2715-2725
Publisher
Oxford University Press (OUP)
Online
2011-10-01
DOI
10.1093/jac/dkr388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
- (2011) G. V. Papatheodoridis et al. GUT
- Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years
- (2011) James Fung et al. HEPATOLOGY
- Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy
- (2011) Chao-Wei Hsu et al. HEPATOLOGY
- Treatment of chronic hepatitis B: Evolution over two decades
- (2011) Man-Fung Yuen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
- (2011) Edward J. Gane et al. LIVER INTERNATIONAL
- Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy
- (2010) Chau-Ting Yeh ANTIVIRAL THERAPY
- Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
- (2010) Eugene R. Schiff et al. Clinical Gastroenterology and Hepatology
- Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
- (2010) Jurriën G.P. Reijnders et al. GASTROENTEROLOGY
- Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
- (2010) Thomas Berg et al. GASTROENTEROLOGY
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
- (2010) S. J. Patterson et al. GUT
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Another cause of autoimmune hepatitis
- (2010) Takeji Umemura et al. HEPATOLOGY
- Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
- (2010) Alexander J.V. Thompson et al. HEPATOLOGY
- Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B
- (2010) Yoshiyasu Karino et al. Hepatology International
- Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy
- (2010) Tatsuya Ide et al. Hepatology International
- HBsAg Seroclearance in Chronic Hepatitis B
- (2010) Ji Hoon Kim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
- (2010) Hong Joo Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
- (2010) Tin Nguyen et al. JOURNAL OF HEPATOLOGY
- Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection
- (2010) Osamu Yokosuka et al. JOURNAL OF HEPATOLOGY
- Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease
- (2010) Jong Ryul Eun et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
- (2010) Jurriën G.P. Reijnders et al. JOURNAL OF HEPATOLOGY
- Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome
- (2010) Wai-Kay Seto et al. JOURNAL OF HEPATOLOGY
- Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B
- (2010) Han Jak Ryu et al. JOURNAL OF MEDICAL VIROLOGY
- Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients
- (2010) L.Y. Lin et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine
- (2010) Rifaat Safadi et al. LIVER INTERNATIONAL
- Continuous antiretroviral therapy decreases bone mineral density
- (2009) Birgit Grund et al. AIDS
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
- (2009) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatitis B and C virus-related carcinogenesis
- (2009) J. Fung et al. CLINICAL MICROBIOLOGY AND INFECTION
- Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA
- (2009) Jung Im Seok et al. HEPATOLOGY
- Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
- (2009) Florian van Bömmel et al. HEPATOLOGY
- Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
- (2009) Josephine Simonetti et al. HEPATOLOGY
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
- (2009) Daniel J. Tenney et al. HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Mitochondrial myopathy caused by clevudine therapy in chronic hepatitis B patients
- (2009) Won Young Tak et al. HEPATOLOGY RESEARCH
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- (2009) Nao Kurashige et al. JOURNAL OF GASTROENTEROLOGY
- Clevudine myopathy in patients with chronic hepatitis B
- (2009) Byung Kook Kim et al. JOURNAL OF HEPATOLOGY
- Control of cccDNA function in hepatitis B virus infection
- (2009) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- The replication cycle of hepatitis B virus
- (2009) Stephan Urban et al. JOURNAL OF HEPATOLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
- Prevention and management of drug resistance for antihepatitis B treatment
- (2009) Man-Fung Yuen et al. LANCET INFECTIOUS DISEASES
- Efficacy and Safety of Entecavir in Patients With Chronic Hepatitis B and Advanced Hepatic Fibrosis or Cirrhosis
- (2008) Eugene Schiff et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
- (2008) Man–Fung Yuen et al. GASTROENTEROLOGY
- 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
- (2008) Yun–Fan Liaw et al. GASTROENTEROLOGY
- Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
- (2008) Patrick Marcellin et al. HEPATOLOGY
- Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance
- (2008) Carl J. Baldick et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase
- (2008) Egor P. Tchesnokov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
- (2008) Joseph J.Y. Sung et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
- (2008) Carl J. Baldick et al. JOURNAL OF HEPATOLOGY
- Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
- (2008) Stéphanie Villet et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B
- (2008) JOURNAL OF HEPATOLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Hepatitis B — New Goals, New Treatment
- (2008) Ching-Lung Lai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatitis B viruses: Reverse transcription a different way
- (2008) Michael Nassal VIRUS RESEARCH
- Clinical features of adverse reactions associated with telbivudine
- (2008) Xue-Song Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation